NCT06739122: A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- State
- Under way
- Phase
- Phase 3
- People
- 55 planned
- Started
- 10 Jan 2025
- Primary completion
- Dec 2027
- Arms
- Dulaglutide
- Results
- None posted
- 18 Dec 2024: Trial registered
- 10 Jan 2025: Trial started